Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 42, 2013 - Issue 7
386
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Letter from the Editor

Pages 505-509 | Published online: 05 Sep 2013

References

  • Al-Shobaili HA, Al Robaee AA, Alzolibani AA, Rasheed Z. (2013). Immunological studies of reactive oxygen species damaged catalase in patients with systemic lupus erythematosus: Correlation with disease activity index. Immunol Invest, 42, 191–203
  • Ávalos-Martínez CE, Rodríguez-Alba JC, Berrón-Ruiz L, et al. (2013). Measurement of suppressor activity of T CD4CD25 T reg cells using bromodeoxyuridine incorporation assay. Immunol Invest, 42, 369–81
  • Ban JY, Kim MK, Park SW, Kwon KH. (2012). Interleukin-1 beta polymorphisms are associated with lymph node metastasis in Korean patients with papillary thyroid carcinoma. Immunol Invest, 41, 888–905
  • Cohen PA, Ko JS, Storkus WJ, et al. (2012). Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape. Immunol Invest, 41, 680–710
  • Cordeau M, Herblot S, Charrier E, et al. (2012). Defects in CD54 and CD86 up-regulation by plasmacytoid dendritic cells during pregnancy. Immunol Invest, 41, 497–506
  • Cruz-Robles D, Chavez-Gonzalez JP, Cavazos-Quero MM, et al. (2009). Association between IL-1B and IL-1RN gene polymorphisms and Chagas' disease development susceptibility. Immunol Invest, 38, 231–9
  • D’Amelio P. (2013). The immune system and postmenopausal osteoporosis. Immun Invest, 42, 544–54
  • Durrant DM, Metzger DW. (2010). Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol Invest, 39, 526–4
  • Dziak R. (2013). The role of sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) in regulation of osteoclastic and osteoblastic cells. Immun Invest, 42, 510–18
  • Erfani N, Khademi B, Haghshenas MR, et al. (2013). Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma. Immunol Invest, 42, 81–90
  • Funaoka H, Dohi Y, Ohgushi H, et al. (2010). Development of a high-specificity enzyme-linked immunosorbent assay (ELISA) system for the quantification and validation of intact rat osteocalcin. Immunol Invest, 39, 54–73
  • Gomes DAS, Pires JR, Zuza EP, et al. (2009). Myeloperoxidase as inflammatory marker of periodontal disease: Experimental study in rats. Immunol Invest, 38, 117–22
  • Haile LA, Greten TF, Korangy F. (2012). Immune suppression: The hallmark of myeloid derived suppressor cells. Immunol Invest, 41, 581–94
  • Harden JL, Egilmez NK. (2012). Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest, 41, 738–64
  • Horwood NJ. (2013). Immune cells and bone: Coupling goes both ways. Immunol Invest, 42, 532–43
  • Jha HC, Srivastava P, Prasad J, Mittal A. (2011). Chlamydia pneumoniae heat shock protein 60 enhances expression of ERK, TLR-4 and IL-8 in atheromatous plaques of coronary artery disease patients. Immunol Invest, 40, 206–22
  • Kadkhodazadeh M, Baghani Z, Ebadian AR, et al. (2013). IL-17 gene polymorphism is associated with chronic periodontitis and peri-implantitis in Iranian patients: A cross-sectional study. Immunol Invest, 42, 156–63
  • Kohanbash G, Okada H. (2012). Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development. Immunol Invest, 41, 658–79
  • Jackson SR, Berrien-Elliott MM, Meyer JM, et al. (2013). CD8+ T cell exhaustion during persistent viral infection is regulated independently of the virus-specific T cell receptor. Immunol Invest, 42, 204–20
  • Latella MC, de Gaetano M, Di Castelnuovo A, et al. (2009). Interleukin 1 gene cluster, myocardial infarction at young age and inflammatory response of human mononuclear cells. Immunol Invest, 38, 203–19
  • Lee J, Lim KT. (2013). Protection against cyclophosphamide-induced myelosuppression by ZPDC glycoprotein (24 kDa). Immunol Invest, 42, 61–80
  • Liu M, Clemons KV, Johansen ME, et al. (2012). Saccharomyces as a vaccine against systemic candidiasis. Immunol Invest, 41, 847–55
  • Manjili MH. (2012). Phenotypic plasticity of MDSC in cancers. Immunol Invest, 41, 711–21
  • Monu NR, Frey AB. (2012). Myeloid-derived suppressor cells and anti-tumor T cells: A complex relationship. Immunol Invest, 41, 595–613
  • Myneni SR, Settem RP, Sharma A. (2013). Bacteria take control of Tolls and T cells to destruct jaw-bone. Immunol Invest, 42, 519–31
  • Negrini Tde C, Ferreira LS, Alegranci P, et al. (2013). Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii. Immunol Invest, 42, 36–48
  • Noack B, Gorgens H, Lorenz K, et al. (2009). TLR4 and IL-18 gene variants in chronic periodontitis: Impact on disease susceptibility and severity. Immunol Invest, 38, 297–310
  • Obermajer N, Wong JL, Edwards RP, et al. (2012). PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells. Immunol Invest, 41, 635–57
  • Park S, Kang S, Min KH, et al. (2013). Age-associated changes in microRNA expression in bone marrow derived dendritic cells. Immunol Invest, 42, 179–90
  • Rafferty BJ, Li G, McGee DW. (2010). Activation of the alpha3 integrin affects TRAF6 function in the IL-1 signaling pathway of CACO-2 epithelial cells. Immunol Invest, 39, 1–15
  • Salah H, Atfy M, Fathy A, et al. (2010). The clinical significance of OPG/sRANKL ratio in thalassemia patients suffering from osteopenia or osteoporosis in Egyptian patients. Immunol Invest, 39, 820–32
  • Solito S, Pinton L, Damuzzo V, Mandruzzato S. (2012). Highlights on molecular mechanisms of MDSC-mediated immune suppression: Paving the way for new working hypotheses. Immunol Invest, 41, 722–37
  • Souza PPC, Lerner UH. (2013). The role of cytokines in inflammatory bone loss. Immun Inv, 42, 555–622
  • Tunceroglu H, Shah A, Porhomayon J, Nader ND. (2013). Biomarkers of lung injury in critical care medicine: Past, present, and future. Immunol Invest, 42, 247–61
  • Velaga S, Ukena SN, Hopting M, et al. (2013). Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation. Immunol Invest, 42, 18–35
  • Zoghi S, Amirghofran Z, Nikseresht A, et al. (2011). Cytokine secretion pattern in treatment of lymphocytes of multiple sclerosis patients with fumaric acid esters. Immunol Invest, 40, 581–96

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.